Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06861244 · ClinicalTrials.gov registry record · Phase 2
Embryonal Tumor With Multilayered Rosettes
A Phase 2 study of Embryonal Tumor With Multilayered Rosettes and Embryonal Tumor With Multilayered Rosettes, Nos, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
- 4
- Study locations
NCT06861244 is a Phase 2 study of Embryonal Tumor With Multilayered Rosettes and Embryonal Tumor With Multilayered Rosettes, Nos that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 134-participant average among 3 other Embryonal Tumor With Multilayered Rosettes trials with a reported enrollment target (48% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06861244, a Phase 2 study of Embryonal Tumor With Multilayered Rosettes and Embryonal Tumor With Multilayered Rosettes, Nos, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is an open-label, comprehensive, iterative investigation of evaluating the use of induction chemotherapy, high-dose chemotherapy, and focal radiation therapy in children with newly diagnosed Embryonal Tumor With Multilayered Rosettes (ETMR).
Conditions Studied
Interventions
- DRUG Temozolomide
- RADIATION Radiotherapy (RT)
- DRUG Chemotherapy Drug, Cancer - Physician's Choice
- PROCEDURE Non-Investigational Surgical Resection
- PROCEDURE Tumor Tissue Sample
Study Locations (4)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- University of California, San Francisco - San Francisco
Maryland
- Johns Hopkins University - Baltimore
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-03-06 |
| Est. Completion | 2032-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06861244
The ClinicalTrials.gov registry entry for NCT06861244 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 3 other Embryonal Tumor With Multilayered Rosettes trials with a reported enrollment target (48% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Embryonal Tumor With Multilayered Rosettes appearing as the primary indexed condition, and to 5 interventions - of which Temozolomide is the first listed.
NCT06861244 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT06861244 about?
NCT06861244 is a clinical study titled "Embryonal Tumor With Multilayered Rosettes". This is an open-label, comprehensive, iterative investigation of evaluating the use of induction chemotherapy, high-dose chemotherapy, and focal radiation therapy in children with newly diagnosed Embryonal Tumor With Multilayered Rosettes (ETMR).
What is the current status of trial NCT06861244?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2025-03-06. Estimated completion is 2032-03-31.
What conditions does trial NCT06861244 study?
This clinical trial studies the following conditions: Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos.
What interventions are being tested in trial NCT06861244?
The interventions under investigation include: Temozolomide (DRUG), Radiotherapy (RT) (RADIATION), Chemotherapy Drug, Cancer - Physician's Choice (DRUG), Non-Investigational Surgical Resection (PROCEDURE), Tumor Tissue Sample (PROCEDURE).
Who is sponsoring clinical trial NCT06861244?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06861244 being conducted?
This trial has 4 study locations across Alabama, California, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Embryonal Tumor With Multilayered Rosettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
RECRUITING
-
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
RECRUITING · Phase 1
-
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RECRUITING · Phase 1
Explore more on PlainTrial
Embryonal Tumor With Multilayered Rosettes
All registered trials for this condition
Embryonal Tumor With Multilayered Rosettes, Nos
All registered trials for this condition
Alabama
All trials with a study site in Alabama
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.